Literature DB >> 15481884

Molecular basis of beta-thalassemia in the population of Tunisia.

Slaheddine Fattoum1, Taeib Messaoud, Amina Bibi.   

Abstract

The present study attempts to delineate the spectrum of beta-thalassemia (thal) mutations in Tunisia by studying a large population from different parts of the country. A total of 285 unrelated subjects, 190 of whom had beta-thal major, 72 with Hb S/beta-thal, one with Hb C/beta-thal, one with Hb O-Arab/beta-thal and 21 beta-thal carriers, were studied. The molecular defects were detected in 97.7% of the beta-thalassemic chromosomes (n=475). Nineteen different beta-thalassemic alleles were identified. Two mutations, namely codon 39 (C-->T) and IVS-I-110 (G-->A) accounted for 70.0% of the studied chromosomes, followed by IVS-I-1 (G-->A) (4.5%). Five other mutations, frameshift codon (FSC) 44 (-C), codon 30 (G-->C), IVS-I-2 (T-->G), IVS-II-745 (C-->G), and FSC 6 (-A), are not uncommon in this population, while the remaining 11 mutations, IVS-I-5 (G-->A), -30 (T-->A), codons 25/26 (+T), IVS-I-6 (T-->C), FSC 5 (-CT), IVS-II-848 (C-->A), FSC 8 (-AA), -87 (C-->G), IVS-I-5 (G-->C), IVS-II-1 (G-->A) and IVS-II-849 (A-->C) are quite rare; four of these have not been previously reported in the Tunisian population. Potential origin and spread of these mutations to Tunisia are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481884     DOI: 10.1081/hem-120040307

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  8 in total

1.  The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes.

Authors:  Imed Touhami; Slaheddine Fattoum; Amina Bibi; Hajer Siala; Taieb Messaoud; Donia Koubaa; Rafik Mankai; Zakia Bartagi; Daniel Le Gallais
Journal:  Eur J Appl Physiol       Date:  2009-12-16       Impact factor: 3.078

2.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

3.  Setup of a Protocol of Molecular Diagnosis of β-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC).

Authors:  Chaima Abdelhafidh Sahli; Ikbel Ben Salem; Latifa Jouini; Naouel Laouini; Rym Dabboubi; Sondes Hadj Fredj; Hajer Siala; Rym Othmeni; Boutheina Dakhlaoui; Slaheddine Fattoum; Amina Bibi; Taieb Messaoud
Journal:  J Clin Lab Anal       Date:  2016-04-18       Impact factor: 2.352

4.  alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

Authors:  H Siala; F Ouali; T Messaoud; A Bibi; S Fattoum
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

5.  Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.

Authors:  L Jouini; C A Sahli; N Laaouini; F Ouali; I Ben Youssef; B Dakhlaoui; R Othmeni; F Ouennich; S Hadj Fredj; H Siala; M Becher; N E Toumi; S Fattoum; R Hafsia; A Bibi; T Messaoud
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

6.  Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect.

Authors:  Slaheddine Fattoum
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-10       Impact factor: 2.576

7.  Molecular heterogeneity of β-thalassemia variants in the Eastern region of Morocco.

Authors:  Ihab Belmokhtar; Saida Lhousni; Mounia Elidrissi Errahhali; Ayad Ghanam; Manal Elidrissi Errahhali; Zaina Sidqi; Meryem Ouarzane; Majida Charif; Mohammed Bellaoui; Redouane Boulouiz; Noufissa Benajiba
Journal:  Mol Genet Genomic Med       Date:  2022-05-26       Impact factor: 2.473

8.  Epidemiological and molecular study of hemoglobinopathies in Mauritanian patients.

Authors:  Taher Mahmoud; Chaima Sahli; Sondess Hadj Fredj; Yessine Amri; Rim Othmani; Ghaber S Mohamed; Ekhtelbenina Zein; Taieb Messaoud
Journal:  Mol Genet Genomic Med       Date:  2022-09-15       Impact factor: 2.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.